Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 214, Issue 10, Pages 2817-2827Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20171069
Keywords
-
Categories
Funding
- National Institutes of Health [R01HL04880, P01HL032262, P30DK049216, R01DK53298, U01HL10001, R24DK092760]
Ask authors/readers for more resources
Hematopoietic stem cell transplantation (HSCT) is an important therapy for patients with a variety of hematological malignancies. HSCT would be greatly improved if patient-specific hematopoietic stem cells (HSCs) could be generated from induced pluripotent stem cells in vitro. There is an incomplete understanding of the genes and signals involved in HSC induction, migration, maintenance, and niche engraftment. Recent studies in zebrafish have revealed novel genes that are required for HSC induction and niche regulation of HSC homeostasis. Manipulation of these signaling pathways and cell types may improve HSC bioengineering, which could significantly advance critical, lifesaving HSCT therapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available